What we fund

  • Research and development of medical devices, active implantable devices and in vitro diagnostic devices as defined by the relevant EU directives, across all areas of existing or emerging healthcare needs
  • Research and development of technologies or interventions specified by Challenge Awards themes
  • Product or technology development required to enable a technology for clinical use, which may include manufacturing, intellectual property protection, freedom to operate and market analysis or business case development
  • Research and development of techniques or technologies from a different industry sector, which could have a potential impact if applied in a healthcare setting
  • Feasibility studies if a technology from a sector other than health is being developed
  • Studies to provide data relating to safety and effectiveness of a device including first-in-man and pivotal studies
  • Health economic analyses and clinical utility studies looking at a device’s real-life implementation and use
  • CE marking and other regulatory requirements including any associated safety trials
  • Activities associated with the adoption of new technology
  • Training associated with the implementation of new technology 

Projects must have already demonstrated ‘proof of principle’. Applicants are expected to have generated experimental data to support the case for further development and illustrate technical feasibility. Early stage research or discovery science is not fundable.

Work packages must not include animal studies or work on animal tissues. If animal studies are required as part of the project, we expect applicants to seek parallel funding to cover such studies, details of which can be provided in the application form.